IMRT-based optimization approaches for volumetric modulated single arc radiotherapy planning
Abstract
This paper reports on an evaluation of 5 RapidArc® optimization approaches vs IMRT. This study includes 11 patients with adenocarcinoma of the prostate. Rectal Normal Tissue Complication Probability is used as a constraint in a dose escalation. RapidArc® rectal NTCP’s are lower than those of IMRT (p
=
0.007). This allows a mean dose escalation of 2.1
Gy([0.7
Gy,3.5
Gy]).
Keywords: RapidArc®, VMAT, Dose escalation, Prostate cancer
To access this article, please choose from the options below
PII: S0167-8140(10)00063-0
doi:10.1016/j.radonc.2010.01.012
© 2010 Elsevier Ireland Ltd. All rights reserved.
